SE8004454L - Forfarande for framstellning av oximorfon - Google Patents

Forfarande for framstellning av oximorfon

Info

Publication number
SE8004454L
SE8004454L SE8004454A SE8004454A SE8004454L SE 8004454 L SE8004454 L SE 8004454L SE 8004454 A SE8004454 A SE 8004454A SE 8004454 A SE8004454 A SE 8004454A SE 8004454 L SE8004454 L SE 8004454L
Authority
SE
Sweden
Prior art keywords
oximorphone
procedure
manufacturing
utilizing
lewis base
Prior art date
Application number
SE8004454A
Other languages
English (en)
Inventor
M L Wilson
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of SE8004454L publication Critical patent/SE8004454L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polarising Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8004454A 1978-10-19 1980-06-16 Forfarande for framstellning av oximorfon SE8004454L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
SE8004454L true SE8004454L (sv) 1980-06-16

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8004454A SE8004454L (sv) 1978-10-19 1980-06-16 Forfarande for framstellning av oximorfon

Country Status (16)

Country Link
JP (1) JPS55501025A (sv)
AU (1) AU5189779A (sv)
BE (1) BE879494A (sv)
CA (1) CA1108132A (sv)
CS (1) CS211364B2 (sv)
DK (1) DK258280A (sv)
ES (1) ES485154A1 (sv)
FI (1) FI793235A (sv)
FR (1) FR2439201A1 (sv)
GB (1) GB2049680A (sv)
IL (1) IL58489A0 (sv)
IT (1) IT7969032A0 (sv)
NL (1) NL7920126A (sv)
NO (1) NO793297L (sv)
SE (1) SE8004454L (sv)
WO (1) WO1980000841A1 (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
ES2129395T3 (es) * 1989-10-16 1999-06-16 Us Health Sintesis total de enantiomeros de nortebaina, normorfina, noroximorfona y sus derivados a traves de productos intermedios n-nor.
WO2003004031A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CA2644095A1 (en) 2006-03-02 2007-09-13 Mallinckrodt Inc. Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
LT2273983T (lt) 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
AU2010275754B2 (en) 2009-07-22 2014-05-15 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive opioids
EP2456427B1 (en) 2009-07-22 2015-03-04 Grünenthal GmbH Hot-melt extruded controlled release dosage form
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
WO2012028319A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising inorganic salt
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
LT2736497T (lt) 2011-07-29 2017-11-10 Grünenthal GmbH Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
AU2013248351B2 (en) 2012-04-18 2018-04-26 Grunenthal Gmbh Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
EA032465B1 (ru) 2013-07-12 2019-05-31 Грюненталь Гмбх Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
CN106572980A (zh) 2014-05-12 2017-04-19 格吕伦塔尔有限公司 包含他喷他多的防篡改即释胶囊制剂
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
AU2016251854A1 (en) 2015-04-24 2017-10-19 Grunenthal Gmbh Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
WO1980000841A1 (en) 1980-05-01
NL7920126A (nl) 1980-08-29
ES485154A1 (es) 1980-06-16
AU5189779A (en) 1980-04-24
IT7969032A0 (it) 1979-10-18
GB2049680A (en) 1980-12-31
CS211364B2 (en) 1982-02-26
CA1108132A (en) 1981-09-01
BE879494A (fr) 1980-02-15
JPS55501025A (sv) 1980-11-27
NO793297L (no) 1980-04-22
DK258280A (da) 1980-06-17
IL58489A0 (en) 1980-01-31
FI793235A (fi) 1980-04-20
FR2439201A1 (fr) 1980-05-16

Similar Documents

Publication Publication Date Title
SE8004454L (sv) Forfarande for framstellning av oximorfon
BR7700342A (pt) Processo de fabricacao de cimento portland
YU231482A (en) Process for producing vulcanizable coatchouc
NO148107C (no) Fremgangsmaate for fremstilling av glassmatter
NL7807983A (nl) Werkwijze voor de vervaardiging van een halfgeleiderin- richting.
PT70244A (en) Process for producing an aldehyde-treated allergen
DE3173396D1 (en) Tridecapeptide, process for its preparation and its use
OA06162A (fr) Panneau en résine phénolique expanse et son procédé de fabrication .
NL7610523A (nl) Werkwijze ter vervaardiging van een selectief absorptieoppervlak van een zonnestralingskol- lector.
BR7903036A (pt) Molde para a producao de objetos de vidro
PT66808B (en) Process for preparing 5-m-tolyloxyuracil useful as an anti-ulcer agent
GB2027364B (en) Method of producing cuvettes for flameless atomic absorption spectroscopy
RO77138A (ro) Procedeu de fabricare a cimentului
SE7704110L (sv) Forfarande for framstellning och rening av sekretin
DE2962212D1 (en) Process for making semiconductor components with optoelectronic conversion properties
YU133778A (en) Process for obtaining chemical compositions on the base of titanium-trihalogenide
JPS5212848A (en) Indoor illuminator utilizing solar rays
HU177814B (en) Process for producing trisazo-colouring agent
DE2953230A1 (de) Process for producing oxymorphone
NL7606379A (nl) Werkwijze ter bereiding van een antigene samenstelling.
GB2004557B (en) Process for producing phenolic resins
AR223665A1 (es) Maquina para la fabricacion de objetos de vidrio
IT7949967A0 (it) Procedimento di fabbricazione di alcheni superiori
DD130031A2 (de) Verfahren zur herstellung glasierbarer,dichter sinterkoerper
NL181989C (nl) Werkwijze voor de bereiding van een colemaniet bevattend glasvezelvormend glasgemeng.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8004454-8